K-Beauty Market Briefing — 2026-07-23

Original English analysis for global buyers. Source articles are linked; summaries are newly written, not excerpted.

trade

K-beauty posts a record first half, and Europe is the fastest-moving column

Korean cosmetics exports reached about USD 7.0 billion in the first half of 2026, a record for any January-to-June period and up 27.3% year on year, with the United States holding the top market at roughly USD 1.45 billion (about 20.7% of the total) ahead of China. The steepest growth sits in Europe: shipments to the Netherlands rose 220.4%, Estonia 196.1%, the UK 150.6%, Turkey 87.6% and Poland 72.8%, and second-quarter volume outran the first, signalling the run is still accelerating rather than peaking.

Buyer takeaway: European buyers should read those triple-digit country growth rates as a warning on availability, not just validation, and secure allocation and pricing on priority SKUs now before Q3 order books tighten further.

Source: Issue Insight (Korean)

regulation

Two EU labelling deadlines land in the last days of July

The updated EU common ingredient names glossary under Implementing Decision (EU) 2025/1175, which adds 348 entries for a total of 30,418 INCI names, becomes mandatory from 30 July 2026, so ingredient declarations must match the new nomenclature. One day later, on 31 July 2026, expanded fragrance-allergen labelling under Regulation (EU) 2023/1545 applies to newly placed products, widening the disclosed list from 26 to 82 substances above 0.001% in leave-on and 0.01% in rinse-off products, with existing stock allowed to sell through until 31 July 2028.

Buyer takeaway: European buyers should require suppliers to confirm both the 2025/1175 glossary alignment and the 82-allergen declaration on any artwork for products first placed on the EU market from end-July, because the glossary change carries no sell-through grace period for new launches.

Source: MOFA (Korean Consulate, Frankfurt) (Korean)

demand

Korean brands are converting Europe from export line to shelf presence

The European push is moving from cross-border shipments into physical retail doors: APR's Medicube has entered Sephora across 17 European countries, Boosters' skincare label Equalberry has landed in the UK's Boots as its first European offline listing, and Amorepacific is channelling COSRX, Estra and Innisfree through UK chains including Boots and Superdrug. Monthly Europe-bound cosmetics exports were already running hot earlier in the year, with April shipments up about 75% year on year.

Buyer takeaway: European and UK buyers weighing an exclusive should move while a brand is still pre-retail in their territory, since terms harden sharply once a competing chain secures Sephora, Boots or Superdrug placement.

Source: Edaily (Korean)

investment

Global money is buying into K-beauty by the share, not the whole company

International investors are increasingly taking minority equity in Korean beauty names rather than acquiring them outright: Fidelity's FMR has built a roughly 5.01% position in APR (about 1.87 million shares), making it the company's third-largest holder behind the founder group (34.8%) and the National Pension Service (7.83%). The stake-building runs alongside a wave of K-beauty IPO filings riding last year's record USD 11.4 billion export year.

Buyer takeaway: Buyers should treat a fresh institutional equity stake in a supplier as a signal that capacity and roadmap will now be run to investor timelines, so lock multi-season supply terms before post-raise priorities reshuffle allocation.

Source: Digital Daily (Korean)